Details for New Drug Application (NDA): 020199

✉ Email this page to a colleague

NDA 020199 describes HIVID, which is a drug marketed by Roche and is included in one NDA. Additional details are available on the HIVID profile page.

The generic ingredient in HIVID is zalcitabine. Additional details are available on the zalcitabine profile page.

Summary for 020199

Tradename:	HIVID
Applicant:	Roche
Ingredient:	zalcitabine
Patents:	0

Medical Subject Heading (MeSH) Categories for 020199

Anti-HIV Agents
Antimetabolites
Reverse Transcriptase Inhibitors

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	0.375MG
Approval Date:	Jun 19, 1992	TE:		RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	0.75MG
Approval Date:	Jun 19, 1992	TE:		RLD:	No

Expired US Patents for NDA 020199

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Roche	HIVID	zalcitabine	TABLET;ORAL	020199-001	Jun 19, 1992	⤷ Subscribe	⤷ Subscribe
Roche	HIVID	zalcitabine	TABLET;ORAL	020199-002	Jun 19, 1992	⤷ Subscribe	⤷ Subscribe
Roche	HIVID	zalcitabine	TABLET;ORAL	020199-001	Jun 19, 1992	⤷ Subscribe	⤷ Subscribe
Roche	HIVID	zalcitabine	TABLET;ORAL	020199-002	Jun 19, 1992	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.